ÂÜÀòÂÒÂ×

Prof. Dr. Fiona Thistlethwaite, MB BCHir MRCP, is a Medical Oncology Consultant within the ECMT (Experimental Cancer Medicine Team) at The Christie NHS Foundation Trust and Honorary Professor of Experimental Immunotherapy at The University of Manchester. Fiona has been actively involved in clinical trial development for many years with a research focus on early phase clinical trials in immune-oncology, particularly adoptive cell therapies, combination immunotherapies and immune biomarkers. She is clinical lead for the Advanced Immune and Cell Therapy Team at The Christie and Director of iMATCH (Innovate Manchester Advanced Therapy Centre Hub), one of three Innovate UK funded ATTC (Advanced Therapy Treatment Centres) forming a network with the aim of scaling up activity in the field of cell and gene therapy. Fiona also co-chairs the Manchester Immune-Oncology Network which is connecting scientists and clinicians across this exciting and dynamic field of medicine. She was Christie researcher of the year 2018 and is an ESMO immunotherapy track scientific committee member since 2017.